InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Calise Chris. Director active across 1 company, notably Coeptis Therapeutics Holdings, Inc.. In total, 2 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €8k. Activity tracked since 23 August 2023. The latest transaction was disclosed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条